BioCardia Receives $7,400,000 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    125 Shoreway Road San Carlos, CA 94070
  • Company Description
    BioCardia’s Helix Biotherapeutic Delivery business remains committed to
    being the platform of choice for delivery of therapeutic agents to the
    myocardium. Novel biotherapeutic approaches have enormous promise in
    addressing unmet clinical needs in hundreds of thousands of patients
    suffering from cardiovascular diseases each year. The Helix Biotherapeutic
    Delivery platform is currently the enabling delivery system in use in
    multiple ongoing clinical trials.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

Trending on Xconomy